Search

everythinglearnresearchcommunity

for

Search:↓

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

Neurotrophins, especially NGF, are crucial for pain development and management.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Repeated use of platelet-rich plasma in rats caused increased pain sensitivity.

Repeated PRP injections for hair loss can cause increased pain sensitivity.

The symposium highlighted the skin's role in sensing itch, pain, touch, and pleasure, and discussed new research and techniques for understanding and treating these sensations.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Gut health affects skin diseases, and probiotics might help.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

For sensitive scalp, treatment is personalized and may include specific medications and hydration, while avoiding stress and irritating products.

Sensitive scalp causes discomfort and hair loss, treated with personalized care.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

Recognizing and managing central sensitization and stress is crucial for treating chronic pain.